Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TNX-1500 by Tonix Pharmaceuticals Holding for Heart Transplant Rejection: Likelihood of Approval
TNX-1500 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase I for Heart Transplant Rejection. According to...
TNX-1500 by Tonix Pharmaceuticals Holding for Sicca Syndrome (Sjogren): Likelihood of Approval
TNX-1500 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase I for Sicca Syndrome (Sjogren). According to...
TNX-1500 by Tonix Pharmaceuticals Holding for Kidney Transplant Rejection: Likelihood of Approval
TNX-1500 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase I for Kidney Transplant Rejection. According to...
TNX-1500 by Tonix Pharmaceuticals Holding for Systemic Lupus Erythematosus: Likelihood of Approval
TNX-1500 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase I for Systemic Lupus Erythematosus. According to...
TNX-1500 by Tonix Pharmaceuticals Holding for Rheumatoid Arthritis: Likelihood of Approval
TNX-1500 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase I for Rheumatoid Arthritis. According to GlobalData,...